| Bioactivity | RAG8 peptide is an antagonist for protease-activated receptor 4 (PAR 4), which inhibits late-stage platelet activation, and reduces thrombosis without altering hemostasis or increasing bleeding risk. RAG8 peptide can be used for atherosclerosis research[1]. |
| Sequence | {Pal}-Arg-Ala-Gly-Leu-Phe-Gln-Arg-Ser-NH2 |
| Shortening | {Pal}-RAGLFQRS-NH2 |
| Formula | C56H98N16O11 |
| Molar Mass | 1171.48 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Barrett TJ. Targeting PAR4 to Reduce Atherosclerosis. Arterioscler Thromb Vasc Biol. 2023 Nov;43(11):2179-2182. |